The Growth Hormone Receptor in Growth

Endocrinology and Metabolism Clinics of North America

Volumn 36, Issue 1, 2007, Pages 1-16

  Bougnères, Pierre ^a,b   Goffin, Vincent ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE; JANUS KINASE 2; SOMATOMEDIN C; STAT5 PROTEIN;

AMINO ACID SUBSTITUTION; DRUG EFFICACY; ETHNIC GROUP; FAMILY HISTORY; GENE EXPRESSION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RECOMBINATION; GENOTYPE; GROWTH HORMONE DEFICIENCY; HORMONE DEFICIENCY; HUMAN; NONHUMAN; PHARMACOGENOMICS; PRIORITY JOURNAL; RACE DIFFERENCE; RECEPTOR GENE; REVIEW; SHORT STATURE; SMALL FOR DATE INFANT; SURFACE PLASMON RESONANCE; TREATMENT OUTCOME;

ANIMALS; GROWTH AND DEVELOPMENT; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; MODELS, BIOLOGICAL; PHARMACOGENETICS; POLYMORPHISM, GENETIC; RECEPTORS, SOMATOTROPIN; SIGNAL TRANSDUCTION;

EID: 33847279824     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2006.08.003     Document Type: Review

References (74)

1. Kelly P.A., Djiane J., Postel-Vinay M.C., et al. The prolactin/growth hormone receptor family. Endocr Rev 12 (1991) 235-251
2. Leung D.W., Spencer S.A., Cachianes G., et al. Growth hormone receptor and serum binding protein: purification, cloning, and expression. Nature 330 (1987) 537-543
3. De Vos A.M., Ultsch M., and Kossiakoff A.A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255 (1992) 306-312
4. Brown R.J., Adams J.J., Pelekanos R.A., et al. Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat Struct Mol Biol 12 (2005) 814-821
5. Argetsinger L.S., Campbell G.S., Yang X., et al. Identification of Jak2 as a growth hormone receptor-associated tyrosine kinase. Cell 74 (1993) 237-244
6. Herrington J., and Carter-Su C. Signaling pathways activated by the growth hormone receptor. Trends Endocrinol Metab 12 (2001) 252-257
7. He K., Loesch K., Cowan J.W., et al. Janus kinase 2 enhances the stability of the mature growth hormone receptor. Endocrinology 146 (2005) 4755-4765
8. Loesch K., Deng L., Cowan J.W., et al. Janus kinase 2 influences growth hormone receptor metalloproteolysis. Endocrinology 147 (2006) 2839-2849
9. Strous G.J., dos Santos C.A., Gent J., et al. Ubiquitin system-dependent regulation of growth hormone receptor signal transduction. Curr Top Microbiol Immunol 286 (2004) 81-118
10. Finidori J. Regulators of growth hormone signaling. Vitam Horm 59 (2000) 71-97
11. Moutoussamy S., Kelly P.A., and Finidori J. Growth hormone receptor and cytokine-receptor family signaling. Eur J Biochem 255 (1998) 1-11
12. Kelly P.A., Finidori J., Edery M., et al. The prolactin/growth hormone/cytokine receptor superfamily. In: Lee A.G. (Ed). Biomembranes (1996), JAI Press, Greenwich (UK) 129-145
13. Carter-Su C., and Smit L.S. Signaling via JAK tyrosine kinases: growth hormone receptor as a model system. Recent Prog Horm Res 53 (1998) 61-82
14. Argetsinger L.S., and Carter-Su C. Mechanism of signaling by growth hormone receptor. Physiol Rev 76 (1996) 1089-1107
15. Butler A.A., and Le Roith D. Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles. Annu Rev Physiol 63 (2001) 141-164
16. Colosi P., Wong K., Leong S.R., et al. Mutational analysis of the intracellular domain of the human growth hormone receptor. J Biol Chem 268 (1993) 12617-12623
17. Postel-Vinay M.C., and Finidori J. Growth hormone receptor: structure and signal transduction. Eur J Endocrinol 133 (1995) 654-659
18. Hwa V., Little B., Kofoed E.M., et al. Transcriptional regulation of insulin-like growth factor-I by interferon-gamma requires STAT-5b. J Biol Chem 279 (2004) 2728-2736
19. Chia D.J., Ono M., Woelfle J., et al. Characterization of distinct Stat5b binding sites that mediate growth hormone-stimulated IGF-I gene transcription. J Biol Chem 281 (2006) 3190-3197
20. Woelfle J., Chia D.J., and Rotwein P. Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation. J Biol Chem 278 (2003) 51261-51266
21. Finidori J., and Kelly P.A. Cytokine receptor signalling through two novel families of transducer molecules: Janus kinases, and signal transducers and activators of transcription. J Endocrinol 147 (1995) 11-23
22. Zhou Y., Xu B.C., Maheshwari H.G., et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci U S A 94 (1997) 13215-13220
23. Udy G.B., Towers R.P., Snell R.G., et al. Requirement of Stat5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A 94 (1997) 7239-7244
24. Teglund S., McKay C., Schuetz E., et al. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93 (1998) 841-850
25. Metcalf D., Greenhalgh C.J., Viney E., et al. Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405 (2000) 1069-1073
26. Greenhalgh C.J., and Alexander W.S. Suppressors of cytokine signalling and regulation of growth hormone action. Growth Horm IGF Res 14 (2004) 200-206
27. Greenhalgh C.J., Rico-Bautista E., Lorentzon M., et al. SOCS2 negatively regulates growth hormone action in vitro and in vivo. J Clin Invest 115 (2005) 397-406
28. Coschigano K.T., Clemmons D., Bellush L.L., et al. Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141 (2000) 2608-2613
29. Rowland J.E., Lichanska A.M., Kerr L.M., et al. In vivo analysis of growth hormone receptor signaling domains and their associated transcripts. Mol Cell Biol 25 (2005) 66-77
30. Rowland J.E., Kerr L.M., White M., et al. Heterozygote effects in mice with partial truncations in the growth hormone receptor cytoplasmic domain: assessment of growth parameters and phenotype. Endocrinology 146 (2005) 5278-5286
31. Lupu F., Terwilliger J.D., Lee K., et al. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229 (2001) 141-162
32. Dupont J., and Holzenberger M. Biology of insulin-like growth factors in development. Birth Defects Res C Embryo Today 69 (2003) 257-271
33. Yakar S., Liu J.L., Stannard B., et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A 96 (1999) 7324-7329
34. Sotiropoulos A., Ohanna M., Kedzia C., et al. Growth hormone promotes skeletal muscle cell fusion independent of insulin-like growth factor 1 up-regulation. Proc Natl Acad Sci U S A 103 (2006) 7315-7320
35. Laron Z., Pertzelan A., and Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone-a new inborn error of metabolism?. Isr J Med Sci 2 (1966) 152-155
36. Laron Z. Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome). J Pediatr Endocrinol Metab 12 Suppl 1 (1999) 231-249
37. Laron Z. Growth hormone insensitivity (Laron syndrome). Rev Endocr Metab Disord 3 (2002) 347-355
38. Maamra M., Milward A., Esfahani H.Z., et al. A 36 residues insertion in the dimerization domain of the growth hormone receptor results in defective trafficking rather than impaired signaling. J Endocrinol 188 (2006) 251-261
39. Duquesnoy P., Sobrier M.L., Duriez B., et al. A single amino acid substitution in the exoplasmic domain of human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization. EMBO J 13 (1994) 1386-1395
40. Bernat B., Pal G., Sun M., et al. Determination of the energetics governing the regulatory step in growth hormone-induced receptor homodimerization. Proc Natl Acad Sci U S A 100 (2003) 952-957
41. Gent J., Van Den E.M., van Kerkhof P., et al. Dimerization and signal transduction of the growth hormone receptor. Mol Endocrinol 17 (2003) 967-975
42. Waters M.J., Hoang H.N., Fairlie D.P., et al. New insights into growth hormone action. J Mol Endocrinol 36 (2006) 1-7
43. Ayling R.M., Ross R., Towner P., et al. A dominant-negative mutation of the growth hormone receptor causes familial short stature. Nat Genet 16 (1997) 13-14
44. Ross R.J.M., Esposito N., Shen X.Y., et al. A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein. Mol Endocrinol 11 (1997) 265-273
45. Milward A., Metherell L., Maamra M., et al. Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transduction. J Clin Endocrinol Metab 89 (2004) 1259-1266
46. Tiulpakov A., Rubtsov P., Dedov I., et al. A novel C-terminal growth hormone receptor (GHR) mutation results in impaired GHR-STAT5 but normal STAT-3 signaling. J Clin Endocrinol Metab 90 (2005) 542-547
47. Kofoed E.M., Hwa V., Little B., et al. Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 349 (2003) 1139-1147
48. Chia D.J., Subbian E., Buck T.M., et al. Aberrant folding of a mutant Stat5b causes growth hormone insensitivity and proteasomal dysfunction. J Biol Chem 281 (2006) 6552-6558
49. Fang P., Kofoed E.M., Little B.M., et al. A mutant signal transducer and activator of transcription 5b, associated with growth hormone insensitivity and insulin-like growth factor-I deficiency, cannot function as a signal transducer or transcription factor. J Clin Endocrinol Metab 91 (2006) 1526-1534
50. Rosenfeld R.G. Gender differences in height: an evolutionary perspective. J Pediatr Endocrinol Metab 17 Suppl 4 (2004) 1267-1271
51. Hwa V., Little B., Adiyaman P., et al. Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b. J Clin Endocrinol Metab 90 (2005) 4260-4266
52. Rosenfeld R.G., Kofoed E., Buckway C., et al. Identification of the first patient with a confirmed mutation of the JAK-STAT system. Pediatr Nephrol 20 (2005) 303-305
53. Woods K.A., Camacho-Hubner C., Savage M.O., et al. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335 (1996) 1363-1367
54. Abuzzahab M.J., Schneider A., Goddard A., et al. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 349 (2003) 2211-2222
55. Rosenfeld R.G., and Hwa V. New molecular mechanisms of GH resistance. Eur J Endocrinol 151 Suppl 1 (2004) S11-S15
56. Urbanek M., MacLeod J.N., Cooke N.E., et al. Expression of a human growth hormone (hGH) receptor isoform is predicted by tissue-specific alternative splicing of exon 3 of the hGH receptor gene transcript. Mol Endocrinol 6 (1992) 279-287
57. Esposito N., Paterlini P., Kelly P.A., et al. Expression of two isoforms of the human growth hormone receptor in normal liver and hepatocarcinoma. Mol Cell Endocrinol 103 (1994) 13-20
58. Mercado M., Davila N., McLeod J.F., et al. Distribution of growth hormone receptor messenger ribonucleic acid containing and lacking exon 3 in human tissues. J Clin Endocrinol Metab 78 (1994) 731-735
59. Wickelgren R.B., Landin K.L., Ohlsson C., et al. Expression of exon 3-retaining and exon 3-excluding isoforms of the human growth hormone-receptor is regulated in an interindividual, rather than a tissue-specific, manner. J Clin Endocrinol Metab 80 (1995) 2154-2157
60. Pantel J., Machinis K., Sobrier M.L., et al. Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. J Biol Chem 275 (2000) 18664-18669
61. Ito Y, Makita Y, Matsuo K, et al. Influence of the exon 3 deleted isoform of GH receptor gene on growth response to GH in Japanese children. Horm Res 2005;64(Suppl 1):1-397 [Abstracts of the ESPE/LWPES 7th Joint Meeting Paediatric Endocrinology. Lyon, France, September 21-24, 2005. p. 1-150].
62. Urbanek M., Russell J.E., Cooke N.E., et al. Functional characterization of the alternatively spliced, placental human growth hormone receptor. J Biol Chem 268 (1993) 19025-19032
63. Sobrier M.L., Duquesnoy P., Duriez B., et al. Expression and binding properties of two isoforms of the human growth hormone receptor. FEBS Lett 319 (1993) 16-20
64. Pantel J., Grulich-Henn J., Bettendorf M., et al. Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform. J Clin Endocrinol Metab 88 (2003) 1705-1710
65. Dos Santos C., Essioux L., Teinturier C., et al. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 36 (2004) 720-724
66. Wagner K., Hemminki K., Grzybowska E., et al. Polymorphisms in the growth hormone receptor: a case-control study in breast cancer. Int J Cancer 118 (2006) 2903-2906
67. Binder G., Baur F., Schweizer R., et al. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. J Clin Endocrinol Metab 91 (2006) 659-664
68. Jorge A.A., Marchisotti F.G., Montenegro L.R., et al. Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency. J Clin Endocrinol Metab 91 (2006) 1076-1080
69. Pilotta A., Mella P., Filisetti M., et al. Common polymorphisms of the growth hormone (GH) receptor do not correlate with the growth response to exogenous recombinant human GH in GH-deficient children. J Clin Endocrinol Metab 91 (2006) 1178-1180
70. Blum WF, Machinis K, Shavrikova EP, et al. The growth response to growth hormone (GH) treatment in children with isolated GH deficiency is independent of the presence of the exon 3-minus isoform of the GH receptor (GHR). Horm Res 2005;64(Suppl 1):1-397 [Abstracts of the ESPE/LWPES 7th Joint Meeting Paediatric Endocrinology. Lyon, France, September 21-24, 2005. p. 3-71].
71. Thomas-Teinturier C, Dos Santos C, Bougneres P. The growth hormone receptor polymorphism influences the response of growth hormone-deficient children to GH treatment. Horm Res 2005;64(Suppl 1):1-397 [Abstracts of the ESPE/LWPES 7th Joint Meeting Paediatric Endocrinology. Lyon, France, September 21-24, 2005. p. 1-152].
72. Hirschhorn J.N., and Altshuler D. Once and again-issues surrounding replication in genetic association studies. J Clin Endocrinol Metab 87 (2002) 4438-4441
73. Freedman M.L., Reich D., Penney K.L., et al. Assessing the impact of population stratification on genetic association studies. Nat Genet 36 (2004) 388-393
74. Farrall M. Quantitative genetic variation: a post-modern view. Hum Mol Genet 13 1 (2004) R1-R7